Back

Hypertensive disorders in pregnancy as risk factors for aortic valve calcification and aortic aneurysm in middle age; a Swedish cohort study

29 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Addressing comorbidities during pregnancy Pregnancy and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Karl Bergman

Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

6 More presentations in this session

Presentation thumbnail
Pregnancy outcomes and risk factors for adverse cardiac events in women with congenital heart disease complicated by pulmonary hypertension
Doctor X. Gu (Beijing, CN)
Abstract Slides
Presentation thumbnail
The importance of global area strain in the assessment of the left ventricular systolic function in hypertensive pregnancy
Associate Professor A. Ilic (Novi Sad, RS)
Abstract Slides Video
Presentation thumbnail
Subclinical atherosclerosis in women who have had preeclampsia: a systematic review and meta analysis
Doctor J. Yao (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Incidence and outcomes of critically ill obstetric patients with heart diseases: a retrospective study from a tertiary care centre
Doctor P. Sharma (Lucknow, IN)
Abstract Slides Video
Presentation thumbnail
Optimal ranges for maternal serum potassium and sodium: associations with hypertensive risks and major adverse pregnancy outcomes
Miss F. Yiwen (Tianjin, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Addressing comorbidities during pregnancy

The Event

Event poster

ESC Congress 2025

29 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular impact on risk of preeclampsia, -an epidemiologic cohort study
thumbnail
Congress Session
Predicting and managing maternal cardiovascular risk during pregnancy
thumbnail
Congress Presentation
Pregnancy complications and long-term risk of cardiovascular events in women with heart disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources